Business & Economy · 1 views
AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S.
Source CNBC AI Summary Updated 38m ago
Business & Economy 
Story intelligence Beta
Freshness Fresh Updated 38m ago
Confidence Limited Single-outlet story
Coverage Single outlet
Views 1 Community interest
Read time 1 min ~17 words
AI Summary
U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.
Read full article on CNBCAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are used SUPPORT HAPPENINGNOW · Independent AI News Intelligence
Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.
Support HappeningNowMore from Business & Economy
Continue reading recent Business & Economy coverage